Amplar Home Health Unveils Innovative Adelaide Headquarter
Amplar Home Health, a leading provider of in-home care services in Australia, has unveiled its new headquarters in Adelaide. This purpose-built facility represents a significant step forward in Amplar Health’s…
Chemed’s Q2 2024 Earnings Report Set for July 24, Conference Call on July 25
Chemed Corporation (NYSE: CHE) announced today that it will release its financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, after the close of…
Centene to Host 2024 Q2 Financial Results Call
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to promoting healthier lifestyles, announced today that it will unveil its 2024 second quarter financial results at around 6:00 a.m. ET…
Calidi Announces Reverse Stock Split
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage biotechnology firm pioneering targeted virotherapies, has confirmed that its Board of Directors has sanctioned a reverse stock split of…
MySpaLive Expands to 5 New States with Enhanced Medical Director Coverage & Business Solutions
MySpaLive, a leader in the aesthetics industry, is thrilled to announce its expansion into five new states: Arizona, Arkansas, Oklahoma, Washington, and Georgia. This strategic move aims to provide Registered…
Atara Biotherapeutics, Inc. Announces Inducement Grant
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) has granted 2,200 restricted stock units of its common stock to a newly hired employee. Approved by the Compensation Committee of Atara’s Board of Directors,…
Inogen Appoints New General Counsel and EVP, Business Development to Leadership Team
Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare, has appointed Kevin P. Smith as General Counsel and Executive Vice President, Business Development,…
ABE Technology Introduces AI-Enhanced Cardiac Imaging System “CardioVision”
ABE Technology has launched CardioVision, an innovative cardiac imaging system powered by artificial intelligence. Designed to enhance efficiency and accuracy in cardiac diagnosis, CardioVision integrates advanced AI algorithms to optimize…
Neuranics Wins Deep Tech Investment of the Year at Angel Investment Awards
Neuranics, a Glasgow-based deep tech startup, celebrates winning the Deep Tech Investment of the Year award at the UK Angel Investment Awards. The ceremony took place at the Science Museum…
Correction: Axena Health Secures Two More Insurance Coverage Wins for Leva
Please replace the release issued April 11, 2024 with the following corrected version due to multiple revisions. “Insurance coverage equals access for most women in the U.S.” The updated release…
Diagnostic Imaging Partnership Report 2016-2024: 628 Deals – ResearchAndMarkets.com
ResearchAndMarkets.com has recently introduced the “Diagnostic Imaging Collaboration and Licensing Deals 2016-2024” report, offering an extensive exploration into the diagnostic imaging agreements undertaken by prominent biopharma companies globally. This updated…
FDA Approves Genentech’s Vabysmo PFS for Vision Loss Causes
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo® (faricimab-svoa) 6.0 mg single-dose prefilled…